Skip to content

Aspergillus fumigatus IgM ELISA kit-SERION classic ESR132M

$364.00

Summary

  • Virion/Serion Diagnostic Kit for research use (RUO)
  • Aspergillus fumigatus IgM ELISA Kit
  • Suitable for IgM detection
  • Ready-to-use
  • 96 tests
SKU: ESR132M Category: Tags: , ,
Weight 1 lbs
Dimensions 9 × 5 × 2 in
target

Aspergillus fumigatus reactive IgM

species reactivity

Aspergillus fumigatus

applications

ELISA

assay type

Indirect & quantitative

available sizes

96 tests

Aspergillus fumigatus IgM ELISA Kit ESR132M

kit
Assay type
Indirect ELISA
Research area
Infectious Disease
Sample type
Serum, plasma, whole blood
Notes
Pretreatment of samples with RF-Absorbent (Z200) is recommended for use with IgM ELISA kits to eliminate presence of sample rheumatoid factors and possible false negative results.
Components
Break apart microtiter test strips each with antigen coated single wells 8 x 12 (96 Total)
Standard serum (ready-to-use)2 x 2 mL
Negative control serum (ready-to-use)2 mL
Anti-human-IgM-conjugate (ready-to-use)13 mL
Washing solution concentrate (sufficient for 1000ml)33.3 mL
Dilution buffer2 x 50 mL
Stopping solution15 mL
Substrate (ready-to-use)13 mL
Quality control certificate with standard curve and evaluation table1
Storage
Store at 2-8°C.
Associated products
Aspergillus fumigatus IgA Control Serum (BC132A)
Aspergillus fumigatus IgG Control Serum (BC132G)
Aspergillus fumigatus IgM Control Serum (BC132M)
Aspergillus fumigatus IgA ELISA Kit (ESR132A)
Aspergillus fumigatus IgG ELISA Kit (ESR132G)
Aspergillus fumigatus IgM ELISA Kit (ESR132M)
target relevance
Aspergillus fumigatus
Description
Fungus that causes aspergillosis and invasive fungal infections
Structure
Aspergillus fumigatus is a filamentous fungus belonging to the family Aspergillaceae and is the most common cause of human aspergillosis. The organism is widely distributed in the environment and is commonly found in soil, compost, decaying vegetation, stored grain, and airborne organic matter. Aspergillus fumigatus reproduces through the formation of abundant airborne asexual spores known as conidia, which are readily inhaled by humans on a daily basis. The fungus exhibits thermotolerance and can grow at temperatures exceeding those of many other environmental fungi, contributing to its pathogenic potential. In healthy individuals, inhaled conidia are efficiently cleared by innate immune defenses; however, in immunocompromised hosts or individuals with underlying lung disease, the fungus may germinate and invade tissues. Aspergillus fumigatus is capable of forming hyphae that penetrate host tissues and blood vessels, resulting in significant tissue damage and dissemination.
Diagnosis
The diagnosis of Aspergillus fumigatus infection is performed through microbiological, histopathological, serological, molecular, and radiological methods. Culture of respiratory specimens, bronchoalveolar lavage fluid, or tissue samples may yield Aspergillus species, although culture alone does not always distinguish colonization from invasive disease. Microscopic examination may reveal characteristic septate hyphae with acute-angle branching. Detection of galactomannan antigen and beta-D-glucan in blood or respiratory samples is commonly used to support the diagnosis of invasive aspergillosis. Polymerase chain reaction (PCR) assays provide sensitive detection of Aspergillus DNA and are increasingly used in specialized laboratories. Imaging studies, particularly computed tomography (CT) of the chest, often demonstrate characteristic pulmonary findings such as nodules, cavitary lesions, or the halo sign. Definitive diagnosis may require histopathological evidence of tissue invasion.
Symptoms
Clinical manifestations of Aspergillus fumigatus infection vary according to the host's immune status and underlying lung disease. Allergic bronchopulmonary aspergillosis (ABPA) commonly presents with wheezing, cough, mucus production, and worsening asthma symptoms. Chronic pulmonary aspergillosis may cause persistent cough, fatigue, weight loss, shortness of breath, and hemoptysis. Invasive aspergillosis, which primarily affects severely immunocompromised individuals, often presents with fever, chest pain, cough, shortness of breath, and progressive pulmonary infiltrates despite antibacterial therapy. The infection may disseminate to the brain, kidneys, heart, liver, and other organs, resulting in neurological symptoms, organ dysfunction, and sepsis. Without prompt diagnosis and antifungal treatment, invasive aspergillosis is associated with high morbidity and mortality.

Data

FAQ & Publications

Frequently Asked Questions
What sample types are compatible with the Aspergillus fumigatus IgM ELISA Kit ESR132M?
The kit is suitable for testing serum, plasma, and whole blood samples.
How should the Aspergillus fumigatus IgM ELISA Kit ESR132M be stored to maintain stability?
The kit should be stored at 2-8°C to preserve its components and ensure reliable performance.
Is there a recommended pretreatment step to improve the accuracy of the Aspergillus fumigatus IgM ELISA Kit ESR132M results?
Yes, pretreatment of samples with RF-Absorbent (Z200) is recommended to remove IgM rheumatoid factors, which can cause false negative results.
What type of assay format does the Aspergillus fumigatus IgM ELISA Kit ESR132M employ and how many tests are included?
This is an indirect and quantitative ELISA assay that comes with 96 tests per kit.
Publications
pmid title authors citation
We haven't added any publications to our database yet.

Published literature highly relevant to the biological target of this product and referencing this antibody or clone are retrieved from the PubMed database provided by the United States National Library of Medicine at the National Institutes of Health.

Protocols

relevant to this product
ESR132M protocol

Documents

#
Please enter your product and batch number here.

Reviews

There are no reviews yet.

Only logged in customers who have purchased this product may leave a review.